MedPath

The Epidemiological study on the incidence of childhood community acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Chiba city, Japa

Not Applicable
Conditions
pneumonia
Registration Number
JPRN-UMIN000022325
Lead Sponsor
Department of Infectious Diseases, Medical Mycology Research Center, Chiba University
Brief Summary

The CAP hospitalisation rate per 1000 child-years was 17.7, 14.3 and 9.7 in children aged <5 years and 1.18, 2.64 and 0.69 in children aged 5-15 years in 2008, 2012 and 2018, respectively. There was a 45% and 41% reduction in CAP hospitalisation rates, between the pre-PCV7 and PCV13 periods, respectively. Significant reductions occurred in the proportion of CAP due to PP and PCV13 serotypes. Conversely, no change occurred in the proportion of CAP caused by H. influenzae.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1399
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To investigate the incidence of CAP after the introduction of PCV13 in Chiba city, Japan
Secondary Outcome Measures
NameTimeMethod
To reveal the incidence of bacteriologically confirmed PP in children after the introduction of PCV13
© Copyright 2025. All Rights Reserved by MedPath